Send us Feedback

Novartis AG (NVS)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

NVS » Topics » Investor Relations Program

This excerpt taken from the NVS 6-K filed Feb 9, 2010.

INVESTOR RELATIONS PROGRAM

 

An Investor Relations team manages the Group’s interaction with the international financial community. Several events are held each year to provide institutional investors and analysts various opportunities to learn more about Novartis.

 

Investor Relations is based at the Group’s headquarters in Basel, Switzerland. A team is also located in New York to coordinate interaction with US investors. Information is available on the Novartis website: www.novartis.com/investors. Investors are also welcome to subscribe to a free e-mail service on this site.

 

This excerpt taken from the NVS 6-K filed Feb 9, 2009.

INVESTOR RELATIONS PROGRAM

 

An Investor Relations team manages the Group’s interaction with the international financial community. Several events are held each year to provide institutional investors and analysts various opportunities to learn more about Novartis.

 

Investor Relations is based at the Group’s headquarters in Basel, Switzerland. A team is also located in New York to coordinate interaction with US investors. Information is available on the Novartis website: www.novartis.com/investors. Investors are also welcome to subscribe to a free e-mail service on this site.

 

This excerpt taken from the NVS 20-F filed Jan 28, 2008.

Investor Relations Program

        An Investor Relations team manages the Group's interaction with the international financial community. Several events are held each year to provide institutional investors and analysts various opportunities to learn more about Novartis.

        Investor Relations is based at the Group's headquarters in Basel, Switzerland. A team is also located in New York to coordinate interaction with US investors. Comprehensive information is available on the Novartis website: www.novartis.com/investors. Investors are also welcome to subscribe to a free e-mail service on this site.

161

This excerpt taken from the NVS 6-K filed Feb 14, 2007.
Investor Relations Program

Novartis has an Investor Relations program which includes the following:

·     A full-year results presentation;

·     Investor events focusing on the Novartis R&D pipeline;

·     Themed events, covering areas of interest such as therapeutic advances in medicine, pharmaceutical research or the generics business (Sandoz);

·     One-on-one and group meetings with investors and analysts at a Novartis site or during roadshows at major financial centers;

·     Conference calls for quarterly results or in conjunction with other press releases; and

·     Presentations at broker-sponsored industry conferences.

These activities focus on recently announced activities or financial results and are conducted in line with stock exchange disclosure rules and Regulation FD.

Presentations are regularly posted to the financial community in an archive on the Novartis Investor Relations website, as audio webcasts and/or PDF documents for slide presentations. These presentations are not regularly updated, but reflect the developments within Novartis over time.

Novartis Investor Relations is managed from the global headquarters in Basel, Switzerland. A team of professionals is located in New York to assist in coordinating responses to inquiries from the US. Their contact details as well as an Investor Relations mailbox are made available on the Novartis Investor Relations website

(www.novartis.com/investors).

On the Novartis website, you can also subscribe to the Novartis Investor Relations e-mail distribution system.

86



This excerpt taken from the NVS 20-F filed Jan 31, 2007.

Investor Relations Program

        We have an Investor Relations program which includes the following:

    •
    A full-year results presentation;

    •
    Investor events focusing on the Novartis R&D pipeline;

    •
    Themed events, covering areas of interest such as therapeutic advances in medicine, pharmaceutical research or the generics business (Sandoz);

    •
    One-on-one and group meetings with investors and analysts at a Novartis site or during roadshows at major financial centers;

    •
    Conference calls for quarterly results or in conjunction with other press releases; and

    •
    Presentations at broker-sponsored industry conferences.

These activities focus on recently announced activities or financial results and are conducted in line with stock exchange disclosure rules and Regulation FD.

        Presentations are regularly posted to the financial community in an archive on the Novartis Investor Relations website, as audio webcasts and/or PDF documents for slide presentations. These presentations are not regularly updated, but reflect the developments within Novartis over time. Novartis Investor Relations is managed from the global headquarters in Basel, Switzerland. A team of professionals is located in New York to assist in coordinating responses to inquiries from the US. Their contact details as

165


well as an Investor Relations mailbox are made available on the Novartis Investor Relations website (www.novartis.com/investors).

        On the Novartis website, you can also subscribe to the Novartis Investor Relations e-mail distribution system.

This excerpt taken from the NVS 6-K filed Feb 8, 2006.

INVESTOR RELATIONS PROGRAM

Novartis runs an Investor Relations program, which includes the following:

    •
    A Full-Year Results presentation;

    •
    Investor Events focusing on the Novartis Pharmaceutical Pipeline;

    •
    Themed events, covering areas of interest such as therapeutic advances in medicine, pharmaceutical research or the generics business (Sandoz);

    •
    One-on-one and group meetings with Investors and Analysts at a Novartis site or during roadshows at major financial centers;

    •
    Conference calls for quarterly results or in conjunction with other press releases;

    •
    Presentations at broker-sponsored industry conferences.

These activities focus on recently announced activities or financial results and are conducted in line with stock exchange disclosure rules and Regulation FD.

Presentations to the financial community are regularly posted in an archive on the Investor Relations website, as audio webcasts and/or pdf documents for slide presentations. These presentations are not regularly updated, but reflect the developments within the company over time.

Novartis Investor Relations is managed out of headquarters in Basel, Switzerland. A team of professionals is located in New York to assist in coordinating responses to inquiries from the US. Their contact details as well as an Investor Relations mailbox are made available on the Novartis Investor Relations website (www.novartis.com/investors).

98


Through the Internet there is also an opportunity to sign up for the Investor Relations e-mail distribution system.

This excerpt taken from the NVS 6-K filed Feb 4, 2005.

Investor Relations Program

Novartis runs an Investor Relations program, which includes the following:

    •
    A Full-Year Results presentation;

    •
    Investor Events focusing on the Novartis Pharmaceutical Pipeline;

    •
    Themed events, covering areas of interest such as therapeutic advances in medicine, pharmaceutical research or the generics business (Sandoz);

    •
    One-on-one and group meetings with Investors and Analysts at a Novartis site or during roadshows at major financial centres;

    •
    Conference calls for quarterly results or in conjunction with other press releases;

    •
    Presentations at broker-sponsored industry conferences.

These activities focus on recently announced activities or financial results and are conducted in line with stock exchange disclosure rules and Regulation FD.

Presentations to the financial community are regularly posted in an archive on the Investor Relations website, as audio webcasts and/or pdf documents for slide presentations. These presentations are not regularly updated, but reflect the developments within the company over time.

Novartis Investor Relations is managed out of headquarters in Basel, Switzerland. A team of professionals is located in New York to assist in coordinating responses to inquiries from the US. Their contact details as well as an Investor Relations mailbox are made available on the Novartis Investor Relations website (http://www.novartis.com/investors). Through the Internet there is also an opportunity to sign up for the Investor Relations e-mail distribution system.

96


Board of Directors

Dr. h.c. Daniel Vasella, M.D.
Chairman and CEO,
Swiss, age 51

Helmut Sihler, J.D., Ph.D.
Vice Chairman and
Lead Director,
Austrian, age 74

Hans-Joerg Rudloff
Vice Chairman,
German, age 64

Dr. h.c. Birgit Breuel
German, age 67

Peter Burckhardt, M.D.
Swiss, age 66

Srikant Datar, Ph.D.
Indian, age 51

William W. George
American, age 62

Alexandre F. Jetzer
Swiss, age 63

Pierre Landolt
Swiss, age 57

Ulrich Lehner, Ph.D.
German, age 58

EXCERPTS ON THIS PAGE:

6-K
Feb 9, 2010
6-K
Feb 9, 2009
20-F
Jan 28, 2008
6-K
Feb 14, 2007
20-F
Jan 31, 2007
6-K
Feb 8, 2006
6-K
Feb 4, 2005

RELATED TOPICS for NVS:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki